Famotidine and 4% topical cromolyn sodium for burns

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Jan 2025: Trial registered, NCT06801626
  2. 1 Mar 2025: Trial started, NCT06801626

The trials

NCT06801626: Novel Strategies for Reducing Burn Scar Itch

State
Under way
Phase
Phase 3
People
44 planned
Started
1 Mar 2025
Primary completion
31 Dec 2027
Arms
PLUS Group
Results
None posted
  1. 30 Jan 2025: Trial registered
  2. 1 Mar 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.